IP Library Granted Patent US 12,110,552
Granted Patent B2
US 12,110,552 · App. 16/856,924 · Granted Oct 8, 2024

Methods for simultaneous amplification of target loci

Inventors: Matthew Rabinowitz (San Francisco, CA); Matthew Micah Hill (Belmont, CA); Bernhard Zimmermann (Manteca, CA); Johan Baner (San Francisco, CA); George Gemelos (Portland, OR); Milena Banjevic (Los Altos Hills, CA); Allison Ryan (Belmont, CA); Styrmir Sigurjonsson (San Jose, CA); Zachary Demko (San Francisco, CA)
Assignee: Natera, Inc.
C12Q1/6883C12Q1/6809C12Q1/6811C12Q1/6844C12Q1/6848C12Q1/6851C12Q1/6855C12Q1/6869C12Q1/6874C12Q2600/156
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,110,552
App. No.
16/856,924
Granted
Oct 8, 2024
Kind
B2
Abstract

The invention provides methods for simultaneously amplifying multiple nucleic acid regions of interest in one reaction volume as well as methods for selecting a library of primers for use in such amplification methods. The invention also provides library of primers with desirable characteristics, such as minimal formation of amplified primer dimers or other non-target amplicons.

Claims (23)

1. A method for preparing a biological sample containing DNA from a first individual and a second individual, comprising:

isolating cell-free DNA from the biological sample, wherein the isolated cell-free DNA comprises the DNA from the first individual and DNA from the second individual;

amplifying the isolated cell-free DNA at a plurality of polymorphic loci on one or more chromosomes expected to be disomic, wherein the plurality of polymorphic loci comprises between 200 and 1,000 polymorphic loci, wherein the amplifying comprises amplifying the between 200 and 1,000 polymorphic loci from the cell-free DNA isolated from the biological sample using between 200 and 1,000 distinct primer pairs configure to target the between 200 and 1,000 polymorphic loci in a single reaction volume; and

preparing the isolated cell-free DNA amplified at the polymorphic loci for sequencing.

2. The method of claim 1 , wherein the method further comprises enriching the DNA in the sample at the plurality of polymorphic loci prior to the amplifying step.

3. The method of claim 2 , wherein the enrichment comprises:

obtaining a plurality of target-specific primers designed to hybridize to regions of DNA upstream and downstream of the polymorphic loci;

hybridizing the target-specific primers to the DNA; and

amplifying the DNA using the polymerase chain reaction to form amplicons.

4. The method of claim 2 , wherein the enrichment comprises preferentially enriching the DNA at the plurality of loci to minimize an average degree of allelic bias.

5. The method of claim 1 , wherein the polymorphic loci are SNP loci.

6. The method of claim 5 , wherein the polymorphic loci comprise SNP loci on chromosome 1.

7. The method of claim 5 , wherein the polymorphic loci comprise SNP loci on chromosome 2.

8. The method of claim 5 , wherein the polymorphic loci comprise SNP loci on chromosome 3.

9. The method of claim 1 , wherein sequencing comprises high-throughput sequencing.

10. The method of claim 1 , wherein the cell-free DNA comprises DNA from a fetus or a transplant.

11. The method of claim 1 , wherein the biological sample is a blood sample.

12. The method of claim 1 , wherein the distinct primers are circularizing probes.

13. The method of claim 1 , wherein the distinct primers are configured to target the polymorphic loci via hybridization.

14. The method of claim 1 , wherein the distinct primers comprise PCR primers.

15. The method of claim 1 , wherein the total amount of cfDNA in the sample is between 10 pg and 100 pg.

16. The method of claim 15 , wherein less than or equal to 10, 5, 2, 1, 0.5, 0.1, 0.05, 0.01, or 0.005% of the cfDNA molecules that have a first locus have a mutation in the first locus.

17. The method of claim 15 , wherein amplifying the isolated cell-free DNA comprises amplifying from 72%, 69%, 66%, 63%, 59%, or 56% of available cfDNA template fragment molecules.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2020
From: BABIARZ, JOSHUA; CONSTANTIN, TUDOR POMPILIU; EUBANK, LANE A.; GEMELOS, GEORGE; HILL, MATTHEW; KIRKIZLAR, HUSEYIN ESER; RABINOWITZ, MATTHEW; SAKARYA, ONUR; SIGURJONSSON, STYRMIR; ZIMMERMANN, BERNHARD
To: NATERA, INC.
Reel/Frame 052483/0922 →
Continuity (38)
Continuation 16743724 · Jan 15, 2020
Continuation 16399268 · Apr 30, 2019
Continuation 16140298 · Sep 24, 2018
Continuation 14918544 · Oct 20, 2015
Continuation In Part 14877925 · Oct 7, 2015
Continuation In Part 14692703 · Apr 21, 2015
Continuation In Part 14538982 · Nov 24, 2014
Continuation In Part 14225356 · Mar 25, 2014
Continuation In Part 13780022 · Feb 28, 2013
Continuation In Part 13683604 · Nov 21, 2012
Continuation PCTUS2012058578 · Oct 3, 2012
Continuation In Part 13683604 · Nov 21, 2012
Continuation In Part PCTUS2012058578 · Oct 3, 2012
Continuation In Part 13335043 · Dec 22, 2011
Continuation In Part 13300235 · Nov 18, 2011
Continuation In Part 13110685 · May 18, 2011
Continuation In Part 13300235 · Nov 18, 2011
Continuation In Part 13110685 · May 18, 2011
Continuation In Part 13300235 · Nov 18, 2011
Provisional Application 62148173 · Apr 15, 2015
Provisional Application 62147377 · Apr 14, 2015
Provisional Application 62146188 · Apr 10, 2015
Provisional Application 62066514 · Oct 21, 2014
Provisional Application 61994791 · May 16, 2014
Provisional Application 61987407 · May 1, 2014
Provisional Application 61982245 · Apr 21, 2014
Provisional Application 61683331 · Aug 15, 2012
Provisional Application 61675020 · Jul 24, 2012
Provisional Application 61634431 · Feb 29, 2012
Provisional Application 61542508 · Oct 3, 2011
Provisional Application 61571248 · Jun 23, 2011
Provisional Application 61516996 · Apr 12, 2011
Provisional Application 61448547 · Mar 2, 2011
Provisional Application 61462972 · Feb 9, 2011
Provisional Application 61426208 · Dec 22, 2010
Provisional Application 61398159 · Jun 21, 2010
Provisional Application 61395850 · May 18, 2010
Related Publication 20200318191A1 · Oct 8, 2020